Program Type: ICER
Liis Shea, MA
COVID-19, 2020
An assessment of COVID-19 treatments, including remdesivir and dexamethasone On May 1st, ICER released the results of its initial analyses to inform public debate of pricing for remdesivir (Gilead Sciences) and other future treatments of COVID-19. Working with external academic partners, ICER has developed ICER-COVID models comprising two alternative pricing paradigms for COVID-19 treatments: 1) […]
Recent Comments